文献速递前列腺增生与排尿功能障碍男科与性医学

AMS AdVance男性吊带系统治疗男性压力性尿失禁的前瞻性多中心研究

Effectiveness and Complications of the AMS AdVance™ Male Sling System for the Treatment of Stress Urinary Incontinence: A Prospective Multicenter Study.
PubMed 文献 · Urology · 2018-07-02

这项国际前瞻性多中心观察研究纳入113例前列腺手术后男性压力性尿失禁患者,均行AdVance吊带植入术并随访24个月。结果显示1小时尿垫试验从48.7g降至6.6g,24小时尿垫试验从113.9g降至45.0g,成功率为22.6%,改善率为58.0%,80.6%患者每日使用不超过1片尿垫,并发症罕见。

要点

  • AdVance吊带可有效改善前列腺术后轻中度男性压力性尿失禁。
  • 24个月时1小时和24小时尿垫试验均显著下降(P<0.001)。
  • 12.4%患者需二次干预,Clavien IIIb并发症发生率为2.7%。

核心结论

  • AdVance男性吊带系统是治疗轻中度男性压力性尿失禁的有效方法,24个月结果满意且并发症罕见。

研究设计与样本

  • 国际性、观察性、前瞻性、多中心研究,纳入前列腺手术后男性尿失禁患者,均行相同AdVance植入手术。
  • 患者术前接受24小时尿垫试验,阈值250g;术后6周及3、6、12、24个月随访。
  • 2007年1月至2012年11月共113例患者成功手术。

主要发现

  • 24个月时1小时尿垫试验平均重量从48.7g降至6.6g(P<0.001)。
  • 24小时尿垫试验平均重量从113.9g降至45.0g(P<0.001)。
  • 成功率为22.6%,改善率为58.0%。
  • IQoL和ICIQ-SF评分均显著改善。

关键数值与推荐

  • 成功定义为无尿液漏出且不使用尿垫。
  • 改善定义为漏尿量减少超过50%且每日使用不超过一片尿垫。

临床怎么用

  • 对于前列腺术后轻中度压力性尿失禁男性患者,可考虑AdVance吊带系统作为治疗选择。
  • 术后需随访评估尿垫试验、尿垫使用数量及生活质量问卷。
  • 需告知患者存在二次干预(12.4%)及Clavien IIIb并发症(2.7%)风险。

局限性

  • 本研究为观察性研究,非随机对照设计。
  • 成功定义严格(无漏尿且不用尿垫),成功率仅22.6%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effectiveness and tolerance of the AdVance Male Sling System for the treatment of male stress urinary incontinence in patients after prostatic surgery. METHODS: An international, observational, prospective, multicenter study was conducted on male patients with urinary incontinence after prostatic surgery. Patients underwent a 24-hour pad test with a threshold at 250 g. All patients were operated with the same AdVance implant procedure. They were seen 6 weeks later, and examined again at 3, 6, 12, and 24 months. Incontinence was measured using 1-hour and 24-hour pad tests, the number of protective pads used, ICIQ-SF and IQoL questionnaires. Success was defined as no urinary leakage and no pad use. Patient improvement was defined as a reduction of more than 50% in leakage and no more than one pad used per day. Any perioperative and late complications were documented. RESULTS: From January 2007 to November 2012, 113 patients were successfully operated on. At 24 months after surgery, the mean weight of the 1-hour pad test had decreased from 48.7 g to 6.6 g (P < 0.001) while that of the 24-hour pad test decreased to 45.0 g from 113.9 g (P < 0.001). Success and improvement occurred in 22.6% and 58.0% of the patients, respectively. Seventy-five patients (80.6%) used none or one protective pad daily, and the IQoL and ICIQ-SF scores were both significantly improved. Fourteen patients (12.4%) required a second intervention. Three patients (2.7%) had a Clavien IIIb complication. CONCLUSION: The AdVance Male Sling System is an effective treatment for mild to moderate male stress urinary incontinence. Complications from its use are rare and 24-month results are satisfactory.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Ye H, Haab F, de Ridder D, et al. Effectiveness and Complications of the AMS AdVance™ Male Sling System for the Treatment of Stress Urinary Incontinence: A Prospective Multicenter Study. Urology. 2018. PMID: 30404760. doi:10.1016/j.urology.2018.06.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。